Evofem Biosciences, Inc. (EVFM) Social Stream



Evofem Biosciences, Inc. (EVFM): $0.01

0.00 (-11.11%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

F

Add EVFM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#285 of 403

in industry

EVOFEM BIOSCIENCES INC (EVFM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EVFM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 4 $5 $0.8 $3.075 $0.478 543.31%
2021-12-15 4 $2 $0.75 $1.687 $0.478 252.93%
2022-01-31 4 $3 $0.75 $1.937 $0.478 305.23%
2022-03-03 4 $3 $0.5 $1.875 $0.478 292.26%
2022-04-12 4 $3 $0.57 $1.892 $0.478 295.82%
2022-05-05 4 $44.977 $8.545 $28.373 $0.478 5835.77%
2022-05-09 4 $44.977 $2 $26.736 $0.478 5493.31%
2022-05-25 4 $44.977 $2 $19.74 $0.478 4029.71%
2022-06-02 4 $44.977 $2 $16.492 $0.478 3350.21%
2022-08-04 4 $29.985 $0.75 $7.847 $0.478 1541.63%
2022-08-16 4 $4 $0.75 $2.65 $0.478 454.39%

EVFM reports an average of 2,389.29% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-13 4 3.000 0.750 1.937 0.395 390.38%
2022-03-03 4 3.000 0.530 1.882 0.490 284.08%
2022-03-03 4 3.000 0.500 1.875 0.490 282.65%
2022-05-05 4 44.977 8.545 28.373 0.110 25693.64%
2022-08-16 4 4.000 0.750 2.650 0.478 454.39%

EVFM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.83 3 0 0 1 1 4

The Trend in the Broker Recommendations


EVFM's average broker recommendation rating improved by 0 over the prior 30 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVFM as an investment opportunity.

  • EVFM has a lower variance in analysts' estimates than -1033.13% of all US stocks.
  • EVOFEM BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1128.61% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, EVOFEM BIOSCIENCES INC's average analyst price target is higher than 122.06% of them.
  • EVFM has a greater number of analysts covering the stock than 261% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EVOFEM BIOSCIENCES INC are ETON, EQ, and ENVB.

Is EVFM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!